Professional Documents
Culture Documents
SMNR 2005 Scheerer Jonathan R.
SMNR 2005 Scheerer Jonathan R.
HO
Me
N
O
H
HO
Me
OH
MeO
N
N
Me
atisine
nominine
OMe H
HO
OMe
talatisamine
Jonathan R. Scheerer
25 March 2005
Leading References:
Stern, The Alkaloids, Vol. 4 (Eds.: R.H.F. Manske, H.L. Holmes), Academic Press, New York, 1954, pp. 275.
Stern, The Alkaloids, Vol. 7, 1960, pp. 473. Pelletier, The Alkaloids, Vol. 12, 1970, pp. 1-206. Pelletier, The
Alkaloids, Vol. 18, 1981, pp. 1-103. Wang, X.-T., The Alkaloids, Vol. 59, 2002, pp. 1-280.
Keywords: Alkaloids, Total Synthesis
RN
Biosynthetically divided
into atisine-type and
veatchine-type alkaloids.
H
H
Me
(50)
H
H
(8)
Me
O
O
N
OH
H
H
H
H
atisine
Me
Me
RN
RN
H
H
Me
(40)
hetidine
skeleton
H
Me
(103)
veatchine
RN
OH
hetisane
skeleton
delphinine
skeleton
H
Me
(6)
napelline
skeleton
H
Me
(34)
Diterpene Alkaloids
Isolated from flowering plants of two genera:
Aconitum and Delphinium
Ranunculaceae Family (Buttercup)
O
N
H
Me
OH
OH
atisine
OMe
N
H
Me
OBz
OH
OMe
EtN
OH
OH
HO
MeO
H
MeO
aconitine
1833, toxic!
nominine
Wolfsbane, Aconitum
napellus
Delphinium scaposum
H
Me
ent-CPP
H
H
H
[2.2.2]
[3.2.1]
(H+)
(H+)
O
O
Me
N
H
Me
H
Me
Me
atisine
Me
OH
Me
veatchine
OH
Me
H
Me
RN
RN
H2NR
oxidation
(P450)
H
RN
Mannich
H2NR
Me
atisine
skeleton
Me
RN
Me
Me
H
Me
H
Me
Me
denudatine
skeleton
H
O
Me
H
Me O
O
H
H2NR
H2NR
OH
O
H
Me
H
Me
Mannich
Me
RN
RN
H
Mannich
H
H
Me
hetsine
skeleton
Me
hetidine
skeleton
hetisine-type
delphinine-type
atisine
nominime
talatisamine
OH
OMe
OMe
EtN
N
OH
OH
H
Me
OH
Me
MeO
HO
Me
H
Me
HO
H
H
N
Me
[2.2.2]
[3.3.1]
aza-bridged
preserved
OH
MeO
N
OMe H
[2.2.2]
[3.2.1]
HO
[3.2.1]
[3.2.1]
OMe
RN
N
hetisane
skeleton
delphinine
skeleton
H
Me
Me
Me
N
O
NH2
Me
OH
HN
HO
N
OH
H
Me
MeO
OH
delnudine
N
H
Me
staphisine
(bisditerpene alkaloid)
racemulosine-type
HO
Me
13
O
N
O
20
3-D
16
12
14
9
10
19
17
15
OH
Standard Terpene
Nomenclature and
Numbering
11
7
4
Me
N
Me
HO
OH
Nagata
Muratake
Fukumoto
N
O
Wiesner
Corey
Me
18
Synthetic Efforts:
Masamune, JACS, 1964, 288-292. (four articles)
Pelletier, JACS, 1956, 4144. TL, 1963, 205.
Mander, Aust. J. Chem, 1971, 343.
Wiesner, TL, 1966, 4645.
Nagata, JACS, 1967, 1483. (full paper)
Fukumoto, JACS, 1988, 1963.
Tahara, TL, 1966, 1453. Tet, 1965, 2133.
Okamoto, CPB, 1970, 2135.
van der Baan, Rec. Trav. Chim. Pays-Bas, 1975, 109.
Kametani, JACS, 1976, 8185.
HO
Me
N
H
OH
H
H
Me
MeOH, !
HO
N
O
H
Me
base
atisine
base
HCl
HO
Me
HO
Me
DMSO, !
Cl
HCl
Cl
HO
OH
all synthetic
efforts have
intercepeted
the Pelletier
intermediate
HN
N
H
OH
HO
H
Me
OH
OsO4, 3 days;
KOH, EtOH
H
Me
HO
O
H
OTHP
KOt-Bu,
t-BuOH, !
O
THPO
OH
Br
H
H
Br
Br
30%
H
H
H
H
OTHP
H2, Pd-CaCO3
OTHP
3) MeI, base
60%
H
H
MeO2C
MeO2C
OTHP
Me
HO2C
OTHP
steps
O
Me
H
Me
O
H
H2, Pd/C
Me
H
H
H
O
Me
H
Me
alkaloids,
e.g. atisine
kaurene
O
H
1) (COCl)2; H2NNH2
2) TsOH, (HOCH2)2
1) HNO2, h!,
10 C
O
H
2) LiAlH4
3) Ac2O
H
Me
Me
1) h!, O2
2) LiAlH4
EtN
O
AcN
O
3) Ac2O
OAc
3 steps
H
Me
Me
via acyl
azide and
nitrene
H
Me
AcN
Von Braun
H2NHN
H
Me
Me
5%
Me
BrCN
H
N
H
OAc
H
Me
Pelletier, JACS,
1956, 4144.
TL, 1963, 205.
OH
Me
()-garryine
Masamune, JACS, 1964, 288-292. (four articles)
CO2H
HN
6 steps
()-garryine
OH
Pelletier, JACS,
1956, 4144.
TL, 1963, 205.
CO2Me
AcN
CO2Me
AcN
H
CO2Me
3) NaOMe, MeOH
4) NaOH
Me
1) H2, Pd/C
2) NaOH
AcN
1) CrO3, H2SO4
2) CH2N2
3) (COCl)2
4) CH2N2
CO2Me
CO2Me
1) (COCl)2
2) Me2Cd
3) mCPBA
H
Me
1) NaOH
2) CrO3
3) NaOMe,
(MeO)2CO
O
AcN
O
H
4) NaBH4
5) TsCl, pyr
Me
Me
CO2Me
H
Me
NaOMe, !
xylene
CO2Me
AcN
H
H
Me
Me
atisine
1) NaOH; H+, !
2) NaH, MeI,
DMSO
6 steps
AcN
3) AcOH, HBr
4) NR3, !
5) NaBH4
H
H
Me
OH
Pelletier, JACS,
1956, 4144.
TL, 1963, 205.
OH
H
Me
H
THPO
H
HO
OTHP
Br
KOt-Bu,
t-BuOH, !
OH
THPO
H
H
Br
H
H
Br
OTHP
[3.2.1]
OH
30%
Mander's Solution: Use a trigonal carbon bridge with a better electrophile (N2+)
HO
BF3OEt2
MeNO2
O
N
O
N2
OH
30%
[2.2.2]
HO2C
1) EtO2CCl, NEt3
2) NaN3; !
O
Me
TsOH
OMe
Me
56%
h", allene
78 C
OMe
1) (HSCH2)2, BF3OEt2
2) Raney Ni, H2
80%
3) Li, NH3; H+
HN
H
Me
65%, 3 steps
Me
Stereoselectivity
Discussion
H
O
HN
Me
O
O
N
H
AcN
H
4 steps
H
Me
H
Me
1) NaBH4
2) HCl, THF, !
AcN
O
AcN
H
Me
Me
6 steps
8 steps
OH
AcN
AcN
N2
AcN
Me
NaOEt,
EtOH
H
N
H
H
Me
Me
Pelletier, JACS,
1956, 4144.
TL, 1963, 205.
Me
H
O
O
AcN
H
N
H
H
Me
H
Me
OH
()-garryine
()-atisine
OH
H
Me
OMe
OMe
OMe
CN
CN
Et2AlCl, HCN
Stork, JACS,
1947, 2936.
72%
HCl
equilibration
OMe
1) Na, NH3,
t-BuOH
OMe
1) HCl, !
2) LiAlH4
HN
CN
Me
2) MsCl
3) HCl
Me
87%
MsN
H
Me
1) Ph3PCHOAr
2) H3O+
equatorial alklylation
OH
MsN
H
94%
56%, 3 steps
single isomer
3) MeI, t-BuOK
H
CHO
59%
Et2AlCl, HCN
60%
CN
1) TsOH, (HOCH2)2
2) MeLi; H+
MsN
H
O
3) KOH
H
Me
Me
47%
Nagata, JACS, 1967, 1483.
MsN
MsN
MsN
KOH
4 steps
OMs
OMs
Me
H
Me
Me
Wohl-Ziegler
Me
1) NBS, CCl4
(PhCOO)2
1) Ph3PCH2
2) Li, NH3
AcN
H
2) mCPBA
3) Zn, EtOH
Me
MsN
H
3) Ac2O
4) HCl
KOt-Bu
Me
54%
O
AcN
AcN
H
Me
OH
H
1) Jones Ox.
2) NaBH4
Me
OH
6 steps
Pelletier, JACS,
1956, 4144.
Me
OH
()-atisine
OR
MsN
collidine, !
MsN
H
H
Me
HO
OSO3Ar
MsN
OMs
Me
OH
H+
Me
Me
OAc
Pelletier, JACS,
1956, 4144.
TL, 1963, 205.
OsO4;
KOH, EtOH
Me
MsN
HN
OH
steps
Me
O
N
AcO
H
O
Me
N
H
OH
()-garryine
Me
H
OAc
Cl
Me
OH
()-veatchine
Nagata, JACS, 1967, 1499.
CO2Me
1) BnNH2,HCHO
2) MePPh3Br,
t-AmOK
CO2Me
NaBH4, BF3OEt2;
NMO
NBn
NBn
LA coordinates to N,
blocking bottom face.
77%
1) Wittig
2) H2, Pd/C
BnN
MeO2CN
OMe
OMOM
CHPPh3
3) HCl, MeOH
Me
CHO
MeO2CN
OH
Me
3) Swern
OMOM
OH
Me
MeO2CN
OH
Na, NH3;
EtOH, HCl
Me
MeO
1) Pd/C, HCO2NH4
2) ClCO2Me
83%
80%, 3 steps
MeO2CN
72%
Me
MeO2C
H
O
CO2Me
1) Swern
2) Ph3PCHCO2Me
Me
H
O
CO2Me
LiHMDS,
78 to 0 C
Me
MeO2C
Li
O
Me
X-ray
43%
+8% stereoisomer
Me
1) KOH
2) (COCl)2, DMF
3) DMAP, NaO
AcN
H
Me
1) TMSI
2) AcCl, NaHCO3
MeO2CN
63%
N
CO2Me
MeO2CN
OMe
Me
4) Bu3SnH,
AIBN
48%
O
N
N
H
OH
O
R
R
SnR3
Me
()-atisine
R
R
R
R
Me
Me
Me
Me
AlCl3
39%
MeO2C
H
Me
Wenkert, JACS,
1958, 211.
MeO2C
H
Me
MeO2C
MeO2C
Me OAc
BF3OEt2,
Ac2O
steps
O
O
MeO2C
Me
H
Me
H
Me OH
Pb(OAc)4
I2, h!, 60 C;
KOH, MeOH
AcO
O
H
Me
MeO2C
H
Me
MeO2C
CH3
O
OMe
1) Urea, "
2) LiAlH4
3) Ac2O; NaOH
4) CrO3
1) HNO2
2) H2, Pd/C
AcN
H
Me
AcN
Nagata
3) NaNO2; H2O
4) CH2N2
atisine
H
Me
OH
Me
Me
Br
H
Me
Me
h!
OTHP
OTHP
OTHP
H
Me
Me
BrN3
Me
Me
Br
H
Me
Me
R
N
46%
OH
Br
Me
R
CH3
Br
Me
R
CH3
O
H
R
Me
R
N
Me
OTHP
H
Me
O
OH
allylBr
NaH
EtO2C
NC
O
HN
NH2
HN
O
CN
CN
110 C
[3,3]
Br
THPO
EtN
O
OTHP
HN
EtN
O
O
CN
CN
CN
OMe
OMe
OMe
NaNH2
Br
65%
NC
NC
NC
MeO2C Me
4! cyclization
"con in"
OMe
OMe
CN
HN
Me
180230 C
sealed tube
MeO2C
H
Me
MeO2C
52%
Me
OMe
NC
single isomer
Nagata, JACS,
1967, 1483.
()-atisine
Delphinine-type Alkaloids
talatisamine
MeO
OH
H
OMe
OMe
Me
OH
HO
=
Me
HO
Me
OMe
OH
MeO
H
H
OMe H
HO
OMe
Corey,
Wiesner
H
OMe
MeO
OH
X
OH
OMe
EtN
OMe
MeN
OMe
OMe
H
MeO
H
MeO
chasmanine
MeO
H
MeO
x = OH, delphinine
x = H, 13-desoxydelphinine
EtN
H
H
OH
OH
OMe
OMe
Me
OH
O
O
H
MeO
OH
methylcaconitine
Nicotinic-AcH receptor ligand
highly toxic!
OMe
O
OMe
OMe
AcN
MeO
OMe H
AcN
H
OTs
MeO
OTs
N
Ac
MeO
40%
40%
MeO
OH
OMe
Hg(OAc)2
MeO
N
OMe
OH
N
Ac
OMe
OMe
OMe
H
MeO
N
40%
OMe
OMe
NR3, !
OMe
N
Ac
MeO
OMe
steps
Me
Me
OH
H
OMe H
MeO
OMe
N
Me
EtN
OH
HO
OMe
OH
OMe
()-talatisamine
MeO
Me
O
Me
Me
AlCl3
OH
O
Cl
MeO2C
MeO2C
OMe
OMe
[4+2]
O
O
NAc
CO2Me
Me
MeO
Me
Me
1) TMSN3
2) HOAc, Ac2O
MeO2C
OMe
(Ph3P)2Ni(CO)2
MeO2C
OMe
85%
H
H
N
R
Me
MeO
Me
MeO2C
H
N
R = CO2Me
MeO2C
NHAc
Me
H
Me
AcHN
MeO2C
O
OMe
several days
85 C, 70% HO
Me
OMe
Me
OMe
OAc
OAc
O
HO
AcHN
MeO2C
OMe
1) Ce(NH4)2(NO3)6
2) mCPBA
OH
AcHN
MeO2C
OMOM
AcHN
OHC
OMe
OMe
3) K2CO3, MeOH
OAc
OAc
OH
OMOM
AcHN
HO
h"
K2CO3,
MeOH, !
OMe
95%
1) RMgBr
2) Ac2O
3) H2, Pd/C
4) PDC
BrMg
OMe
O
RMgBr =
MeO
OBn
MeO
OMOM
AcHN
AcO
OMOM
AcHN
AcO
90%
MeO
OBn
OMOM
AcHN
AcO
OMOM
OH
HN
OMe
OMe
OMe
O
MeO
MeO
O
OAc
MeO2C
NaOMe,
MeOH, !
H
MeO
O
HN
OMe
H
MeO
OMOM
OMe
MeN
1) LiAlH(Ot-Bu)3
2) MeI, NaH
OMe
NaSEt,
DMF
120 C
OH
CO2H
OBn
X
MeO
BnO
OMe
OMe
OBn
O
MeN
O
H
O
H
OMe
MeO
OH
OMe
MeO
OMOM
OMe
MeN
95% selective
demethylation
MeN
H
OMe
OMe
MeO
N
Me
MeN
NBS
OMOM
H
MeO
OMe
OMe
MeO
OMe
86%
rt
exo
Zn, HOAc
18-c-6, !
MeN
H
O
H
MeO
OMe
H
OMe
MeO
OMe
x = H, Br
Wieser, Pure Appl. Chem., 1979, 689.
OAc
O
OMe
MeN
H
MeN
H
OMe
MeO
N
Me
180 C
DBN
DMSO
H
MeO
OMe
MeO
1) Br2
dioxane
MeN
=
MeO
H
MeO
OMe
X
MeN
=
N
Me
= (-OCH2)2
MeO
OMe
MeO
N
Me
OMe
OMe
OMe
H
Delphonine
OMe
MeN
=
H
H
MeO
OMe
OH
OMe
OMe
5 steps
OMe
2) TsOH
(HOCH2)2
89%
H
X
Br
OMe
OMe
MeO
OMe
MeN
H
H
OMe
O
Br X
OMe
OMe
MeO
MeO
MeO
OMe
MeN
2) CrO3pyr
OMe
1) H2 (85 psi),
Rh/Al2O3
H
MeO
OMe
1) H2, Pd/C
2) Ac2O
OAc
MeO
OH
H
MeO
MeO
MeO
OMe H
OMe
N
Me
HO
OMe
Hetisine-type Alkaloids
nominime
H
OH
HO
Me
OH
N
Mander
H
Me
Me
OH
Muratake
Me
Winkler
HO
HO
HO
HO
OAc
HO
hetisine
H
Me
BzO
OH
OH
Me
kobusine
H
HO
HO
davisinol
OH
H
OAc
tadzhaconine
pronounced
antiarrhythmic
ED = <0.3 mg/kg
Hetisine
HO
O
R
NH2
Me
O
NBoc
Me
HO
h!
Pyrex
MeCN
86%
EtOH,
PPTS, "
Me
NBoc
Me
Boc
NBoc
84%
MeN
Br
Br
R
CO2Et
N
Me
CO2Et
EtO2C
RMgBr
MgX
THF
O
N
Me
CO2Et
O
Br
R
Br
MeN
O
CO2Et
Br
Me
BrMg
Me
OMe
N
Me
EtO2C
OH
Me
OMe
64%
RMgBr =
OMe
NO2
OMe
SO3Ag
MeN
OAc
OH
Me
O2N
MeN
Br
NO2
53%
AcO
OAc
1) TMSOTf, Ac2O
2) Pd/BaSO4, H2
3) Reduction
4) Acylation (1 ROH)
OH
AcO
(AgBF4, 18%)
Williams and Mander, OL, 2003, 3499.
OMe
OHC
OHC
OHC
PdCl2(PPh3)2,
Cs2CO3, THF, !
Br
OMe
TsOH
HO(CH2)2
65%
H
O
4:1
cis / trans
H
O
mixture subjected
to acetalization
mixture of
diastereomers
O
1) Me2NCH(OMe)2,
160 C
2) BH3NH3, BuLi
3) PivCl, NEt3, DMAP
MOMO
H
H
O
OPiv
H
O
34%
61%
20
OMe
2) TsOH, Me2CO
H
O
O
OPiv
1) BF3OEt2
66%
TsOH
35% (+SM)
~60%, 3 steps
OMe
H
O
65%, 3 steps
OH
PivO
LA
O
O
HO
OPiv
H
H
MOMO
OAc
OH
1) TMSI, HMDS;
NBS
2) MOMCl
3) MeLi
RO
Me
1) Ac2O, pyr
2) PCC
OH
mixture at 3 ROH
Me
Et2AlCN
52%, 5 steps
94%
RO
RO
RO
OH
OH
H
NaBH3CN
OAc
H
H
Me
1) TMSCl, LDA
2) LiAlH4
3) CbzCl
90%
NCbz
Me
NCbz
63%
NC
H
Me O
SnBu3
1) PCC
2) Ohira
alkynlation
RO
RO
RO
Bu3SnH, AIBN,
toluene, !;
3) HCl
73%
SiO2
H
Me
NCbz
H
Me
NCbz
31%
R = -(CH2)2OH
Me
NCbz
57%
Muratake, TL, 2002, 2913.
Muratake, ACIE, 2005, 4646.
RO
H
90%
H
Me
HO
1) SeO2
2) MnO2
Me
HO
H
3) Zn, NH4Cl
NCbz
R = -(CH2)2OH
R = -(CH2)2Br
1) NaBH4, CeCl3
2) Ac2O, pyr
NCbz
94%
OAc
H
Me
NCbz
Me
OH
N
N
Me
nominime
40 steps (0.15%)
fin